Three stories follow a drug trafficker arranging a multi-cartel Fentanyl smuggling operation; an architect, recovering from oxycodone addiction, searching for her missing son; and a university professor who battles unexpected revelations about his employer at a pharmaceutical company, bringing a new \"non-addictive\" painkiller to market.